Spots Global Cancer Trial Database for erlotinib + celecoxib
Every month we try and update this database with for erlotinib + celecoxib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer | NCT00970502 | Cancer of the P... Cancer of the L... Cancer of the N... Paranasal Sinus... Cancer of the H... | erlotinib + cel... | 18 Years - | Icahn School of Medicine at Mount Sinai |